Jointly Provided by the Massachusetts Medical Society and New England Regional Genetics Network
Free CME Webinar Series
Description
Primary care physicians are increasingly encountering situations where diagnosis and treatment will be affected by genetic testing. Because rare disorders are not covered in depth in most medical education curricula, primary care physicians often lack
training to confidently diagnose and manage patients suffering from these illnesses. This webinar series seeks to provide a strong foundational understanding of genetics, tools to support improved decision making, and communication strategies, which
will positively impact patient outcomes regardless of a specific diagnosis.
Target Audience
This webinar series is designed for all providers including Primary Care Physicians, Specialty Physicians, Physician Assistants, and Nurse Practitioners.
Series Learning Objectives
Upon completion of these activities, learners should be able to:
-
Gain foundational understanding of the intersection of genetics in primary care practice
-
Develop strategies to improve timely diagnosis and treatment of rare and genetic conditions
-
Demonstrate effective communication of genetic information to patients, families, and medical specialists
Genetic Testing in Primary Care
Wednesday, December 6, 2023 – 12:00 to 1:00 p.m. ET
This webinar will describe different genetic testing modalities and indications for each. Instances when primary care providers might want to initiate testing themselves before or instead of sending patients to a geneticist will be discussed. In addition,
faculty will share clear guidelines on ordering and documenting to increase the likelihood that insurance will cover testing and will provide an overview of Direct-to-Consumer genetic testing and discuss what to do if your patient brings you their
results.
Going on Metabolism Rounds: Patients with Encephalopathy
Wednesday, January 3, 2024 – 12:00 to 1:00 p.m. ET
The diagnosis of genetic metabolic diseases is frequently missed, especially in the adult population. This is a tragic situation since diagnostic screening tests are readily available and effective therapy can ameliorate or prevent complications. During
this webinar, learners will encounter three patients presenting with acute encephalopathy due to inborn errors: a urea cycle disorder, a disorder causing homocysteinemia, and acute hepatic porphyria.
How Rare is Rare? Why it Pays to Think of Zebras
Wednesday, February 7, 2024 – 12:00 to 1:00 p.m. ET
This webinar will provide information about the prevalence and impact of rare genetic disorders. Faculty will describe the diagnostic and treatment difficulties for patients with a rare genetic disease, highlight the vital role of primary care providers and give
helpful tips to narrow down differential diagnoses. Specific examples will be provided to demonstrate how a good history and intellectual curiosity can change a patient’s life.
Going on Metabolism Rounds: Patients with Muscle Symptoms
Wednesday, March 6, 2024 – 12:00 to 1:00 p.m. ET
The diagnosis of genetic metabolic diseases is frequently missed, especially in the adult population. This is a tragic situation since diagnostic screening tests are readily available and effective therapy can ameliorate or prevent complications. During
this webinar, learners will encounter three patients presenting with muscle symptoms due to inborn errors: Pompe disease, a long chain fatty acid oxidation defect, and glycogen storage disease.
Positive Newborn Screen – Now What?
Wednesday, April 3, 2024 – 12:00 to 1:00 p.m. ET
This webinar will describe the NBS process in each New England state and provide a local contact person for questions. Participants will learn where to access additional information on the specific genetic condition in question and how to help determine
next steps. Faculty will provide clear guidance on what and how to communicate to anxious new parents so that you are both empowered to provide the best care.
Webinar Registration Fees
This is a free webinar series.
This program is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) as part of an award totaling $635,000 with 0% financed with non-governmental sources. The contents are those
of the author(s) and do not necessarily represent the official views of, nor an endorsement by, HRSA, HHS, or the U.S. Government.
Accreditation Statement
These activities have been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Massachusetts Medical Society
and New England Regional Genetics Network. The Massachusetts Medical Society is accredited by the ACCME to provide continuing medical education for physicians.
AMA Credit Designation Statement
The Massachusetts Medical Society designates each live activity for a maximum of 1.00 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
